Description: Vasopressin and Oxytocin by Hans H. Zingg, etc. This monograph provides an overview of the latest advances in the field of vasopressin and oxytocin, taken from the 1997 World Congress of Neurohypophysial Hormones. This conference united the fields of vasopressin, neurohypophysis, and oxytocin in a single joint meeting. FORMAT Hardcover LANGUAGE English CONDITION Brand New Publisher Description This monograph provides a comprehensive overview of the latest advances in the field of vasopressin and oxytocin. In the summer of 1997, scientists from over 20 countries congregated in Montreal for the 1997 World Congress of Neurohypophysial Hormones, a conference that united the fields of vasopressin, neurohypophysis, and oxytocin in a single joint meeting that gave rise to this book. The organization of a joint meeting was prompted by several developments. Specifically the molecular characterization of the vasopressin/oxytocin receptor family made it mandatory to adopt an integrated view and to discuss the vasopressin/oxytocin ligand/receptor family as a whole. To ensure emphasis on novelty, the conference focused on advances made in the late-1990s and also included important contributions by scientist that had not previously been associated with the vasopressin/oxytocin field. Table of Contents Historical Overview: Vasopressin Receptors: A Historical Survey; S. Jard. Biosynthesis of Vasopressin and Oxytocin. Cell-Specific Gene Expression in Oxytocin and Vasopressin Magnocellular Neurons; H. Gainer. Hypothalamic Transcription Factors and the Regulation of the Hypothalamo-Neurohypophysial System; J.P.H. Burbach, et al. POU Domain Factors in Neural Development; M.D. Schonemann, et al. Local Protein Synthesis in Magnocellular Dendrites: Basic Elements and Their Response to Hyperosmotic Stimuli; Dan Ma, J.F. Morris. Vasopressin Gene Expression in Rat Choroid Plexus; A. Chodobski, et al. Neuronal Activity and Release. Electrophysiological Distinctions between Oxytocin and Vasopressin Neurons in the Supraoptic Nucleus; W.E. Armstrong, J.E. Stern. Mechanisms of Neuroendocrine Cell Excitability; G.I. Hatton, Zhenhui Li. Properties of the Transient K+ Current in Acutely Isolated Supraoptic Neurons from Adult Rat; T.E. Fisher, C.W. Bourque. Gaba b Receptors and Supraoptic Neuronal Activity; Q.J. Pittman, et al. Local Glutamatergic and Gabaergic Synaptic Circuits and Metabotropic Glutamate Receptors in the Hypothalamic Paraventricular and Supraoptic Nuclei; J.G. Tasker, et al. Progesterone Regulates Hypothalamic Oxytocin mRNA Levels through Gamma Aminobutyric Acid; A. Thomas, J.A. Amico. Differential Effects of the Neurosteroid Pregnenolone Sulphate on Oxytocin and Vasopressin Neurones in Vitro; J.B. Wakerley, C.M. Richardson. Regulation of Vasopressin Release by Ionotropic Glutamate Receptor Agonists; D.J. Morsette, et al. Role of N-Methy-D-Aspartate (NMDA) Receptors in Vasopressin and Oxytocin Responses to Emotional Stimuli; K. Yagi, et al. Electrophysiological Studies of Oxytocin Neurons in Organotypic Slice Cultures; P. Jourdain, et al. Inhibitory Actions of Nociceptin (Orphanin FQ) on Rat Supraoptic Nucleus Oxytocin and Vasopressin Neurones in Vitro; N. Doi, et al. New Aspects of Firing Pattern Autocontrol in Oxytocin and Vasopressin Neurones; F. Moos, et al. Intrahypothalamic Vasopressin Release: An Inhibitor of Systemic Vasopressin Secretion? M. Ludwig, G. Leng. Differential Central and Peripheral Release of Vasopressin and Oxytocin in Response to Swim Stress in Rats; M. Engelmann, et al. Pregnancy and Aging: Two Model Systems with Altered Release Patterns of Oxytocin and Vasopressin within the Hypothalamus; I. Neumann, et al. Effect of Age and Testosterone on the Vasopressin Response to Dehydration in F344BNF1 Male Rats; J. Catudioc-Vallero, et al. Evidence for Nitric Oxide (NO) Actions throughout the Forebrain Osmoresponsive Circuit; S.M. Luckman. Gaseous Neurotransmitter Modulation of Vasopressin and Oxytocin Release; M.L. Forsling, A. Grossman. Membrane Excitability in the Neurohypophysis; R.A. Wilke, et al. Effects. Vasopressins Depolarizing Action on Neonatal Rat Spinal Lateral Horn Neurons May Involve Multiple Conductances; M. Kolaj, L.P. Renaud. Vasopressin Action in the Mammalian Cerebral Cortex; R. Diaz Brinton, et al. Oxytocin, Vasopressin, and the Neuroendocrine Basis of Pair Bond Formation; T.R. Insel, et al. Central Oxytocin Neurotransmission: Receptor Characterisation and Role in Modulating Limbic Circuits in the Peripartum Period; C.D. Ingram, et al. Targeted Reduction of Oxytocin Expression Provides Insights into Its Physiological Roles; W.S. Young III, et al. Phenotypic Expression of and Oxytocin Peptide Null Mutation in Mice; J.T. Winslow, et al. Antiproliferative Effect of Oxytocin through Specific Oxytocin Receptors in Human Neuroblastoma and Astrocytoma Cell Lines; P. Cassoni, et al. Phosphorylation of Proteins Induced in a Murine Pre-T Cell Line by Neurohypophysial Peptides; H. Martens, et al. Signalling. Molecular Pharmacology of Human Vasopressin Receptors; M. Thibonnier, et al. Molecular Mechanisms Regulating the Effects of Oxytocin on Myometrial Intracellular Calcium; B.M. Sanborn, et al. Receptors: Expression and Regulation. Genomic and Non-Genomic Mechanisms of Oxytocin Receptor Regulation; H.H. Zingg, et al. The Molecular Basis of Oxytocin and Oxytocin Receptor Gene Expression in Reproductive Tissues; R. Ivell, et al. Transcriptional Regulation of the Oxytocin Receptor Gene; T.L. Bale, D.M. Dorsa. Female Reproduction in Mice Lacking the Prostaglandin F Receptor: Roles of Prostaglandin and Oxytocin Receptors in Parturition; Y. Sugimoto, et al. Expression of the Oxytocin Receptor and Oxytocin Gene in Human Oocytes and Preimplantation Embryos; S. Stock, C. Osterlund. Vasopressin Regulates Adrenal Functions by Acting through Different Vasopressin Receptor Subtypes; E. Grazzini, et al. All Three Vasopressin Receptor Sub-Types Are Expressed by Small-Cell Carcinoma; W.G. North, et al. Receptors: Structure/Function. Processing and Ligand-Induced Modifications of the V2 Vasopressin Receptor; H.M. Sadeghi, et al. Molecular Aspects of Vasopressin Receptor Function; T. Schoneberg, et al. Mapping Peptide Antagonist Binding Sites of the Human V1a and V2 Vasopressin Receptors; B. Mouillac, et al. Structure/Function Studies on Receptors for Vasopressin and Oxytocin; M. Wheatley, et al. Identification of a Constitutively Active Mutant of the Human Oxytocin Receptor; B. Chini, et al. Identification of Neurohypophysial Hormone Receptor Domains Involved in Ligand Binding and G. Protein Coupling; R. Postina, et al. Mutations in the Vasopressin V2 Receptor and Aquaporin-2 Genes in Twelve Families with Congenital Nephrogenic Diabetes Insipidus; R. Vargas-Poussou, et al. Functional Study of Two V2 Vasopressin Mutant Receptors Related to NDI: P322S and P322H; D. Morin, et al. Renal Actions of Vasopressin. Studies of Renal Aquaporin-2 Expression during Renal Escape from Vasopressin-Induced Antidiuresis; J.G. Verbalis, et al. Prompt and Sustained Regulation of Aquaporin-2 by Arginine Vasopressin in Collecting Duct Cells and Clinical Implication of Urinary Excretion of Aquaporin-2; San-e Ishikawa, et al. Recent Advances in the Understanding of Water Metabolism in Heart Failure; R.W. Schrier, P.Y. Martin. Antagonists. Nonpeptide Antagonists for Vasopressin Receptors: Pharmacology of SR 121463A, A New Potent and Highly Selective V2 Receptor Antagonist; C. Serradeil-Le Gal. VPA-985, a Nonpeptide Orally Active and Selective Vasopressin V2 Receptor Antagonist; P.S. Chan, et al. Effects of Chronic AVP V2R Blockade in Congestive Heart Failure in Sheep: Comparison with Chronic ACE Inhibition; M. Naitoh, et al. Vasopressin Induces Opposite Changes in Blood Flow in the Skin and the Muscular Circulation; D. Hayoz, et al. Discovery of Novel Selective Hypotensive Vasopressin Peptides: A New Vasodilating Vasopressin Receptor? W.Y. Chan, et al. Safety, Tolerability, and Pharmacokinetics of SR 49059, a V1a Vasopressin Receptor Antagonist, after Repeated Oral Administration in Healthy Volunteers; R. Brouard, et al. Evidence for an Involvement of Vasopressin in Mechanism of Primary Dysmenorrhea and Effect of the Non-Peptide Vasopressin V1a Receptor Antagonist, SR 49059, on the Uterus of Non-Pregnant Women; M. Akerlund, et al. Progress in the Development of Oxytocin Antagonists for Use in Preterm Labor; P.D. Williams, et al. Index. Details ISBN0306459280 Pages 500 Publisher Kluwer Academic Publishers Group Series Advances in Experimental Medicine and Biology Year 1998 ISBN-10 0306459280 ISBN-13 9780306459283 Format Hardcover Imprint Kluwer Academic / Plenum Publishers Subtitle Molecular, Cellular, and Clinical Advances Place of Publication Dordrecht Country of Publication Netherlands DEWEY 612.492 Illustrations Illustrations Edited by Hans H. Zingg Author etc. Short Title VASOPRESSIN & OXYTOCIN Language English Media Book Publication Date 1998-10-00 DOI 10.1604/9780306459283 Series Number v. 449 Audience Professional & Vocational We've got this At The Nile, if you're looking for it, we've got it. With fast shipping, low prices, friendly service and well over a million items - you're bound to find what you want, at a price you'll love! TheNile_Item_ID:159686956;
Price: 183.89 AUD
Location: Melbourne
End Time: 2025-01-05T01:39:30.000Z
Shipping Cost: N/A AUD
Product Images
Item Specifics
Restocking fee: No
Return shipping will be paid by: Buyer
Returns Accepted: Returns Accepted
Item must be returned within: 30 Days
ISBN-13: 9780306459283
Book Title: Vasopressin and Oxytocin
Publisher: Kluwer Academic Publishers Group
Publication Year: 1998
Subject: Biology, Psychiatry
Item Height: 230 mm
Number of Pages: 500 Pages
Language: English
Publication Name: Vasopressin and Oxytocin: Molecular, Cellular, and Clinical Advances: Proceedings of a World Congress on Neurohypophysial Hormones Held in Montreal, Canada, August 8-12, 1997
Type: Textbook
Author: Hans H. Zingg, Etc.
Format: Hardcover
